The Institutional Biosafety Committee (IBC) is the University's primary body responsible for ensuring all practices involving gene technology, biosecurity-regulated materials and biologically-hazardous materials are conducted in accordance with legislation, Australian Standards (including AS2243.3 Safety in Laboratories – Microbiological Safety and Containment), codes of practice, and licensing requirements.
The Committee will oversee current dealings and evaluate future opportunities, including collaborative projects with external organisations, and will consider the ethical aspects of proposals and applications they evaluate. The Committee will provide recommendations to the Deputy Vice Chancellor (Research) regarding development and implementation of relevant University policies and procedures, and may act on behalf of the Deputy Vice Chancellor (Research) in an authoritative capacity to instigate these procedures.
The Institutional Biosafety Committee also performs the function of a management committee for all practices involving Security Sensitive Biological Agents (SSBAs) and materials on the Defence Strategic Goods List.
The IBC Terms of Reference can be viewed here: IBC ToR (PDF 228kb)
Containment principles and practices to prevent exposure to biological agents and toxins, or their accidental release.
Regulations and preventative measures for reducing the risk posed by invasive pests and diseases.
Techniques and activities concerned with artificial modification of genes and synthetic biology.